✦ LIBER ✦

Efficacy and Safety of Canakinumab in a Large Cohort of Cryopyrin-Associated Periodic Syndrome (CAPS) Patients across All Severity Phenotypes

✍ Scribed by Cartwright, R.; Smith, J.; Hawkins, P.; Kuemmerle-Deschner, J.; Hachulla, E.; Kone-Paut, I.; Hoyer, J.; Quartier, P.; Gattorno, M.; Widmer, A.

Book ID: 119285063
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 44 KB
Volume: 127
Category: Article
ISSN: 1097-6825
DOI: 10.1016/j.jaci.2010.12.901

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of canakinumab thera

Efficacy and safety of canakinumab therapy in paediatric patients with cryopyrin-associated periodic syndrome: a single-centre, real-world experience

✍ Russo, R. A. G.; Melo-Gomes, S.; Lachmann, H. J.; Wynne, K.; Rajput, K.; Elefthe 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 112 KB

Efficacy and Safety of Canakinumab (ACZ8

Efficacy and Safety of Canakinumab (ACZ885), a Fully Human Anti-Interleukin-1b-Antibody, in Cryopyrin Associated Periodic Fever Syndrome Results of a Multicenter, Randomized, Double-blind, Phase III Study

✍ Lachman, H.; Kone-Paut, I.; Kuemmerle-Deschner, J.; Leslie, K.; Hachulla, E.; Qu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB